PharmaLegacy has reaffirmed that all of its non-human primates (NHPs) are farm-raised for research use. Supplier providence and detailed animal information can be provided to all clients upon request.

The US Department of Justice is investigating primates being illegally smuggled from Cambodia for research purposes. This has led to concerns about a shortage of primates for biomedical research. The PharmaLegacy team has re-reviewed the records for all of our NHP and none have been imported from Cambodia. If you have used our models in the past or are planning a study for the future, you can be assured purpose-bred animals are used in your research at PharmaLegacy.

Furthermore, PharmaLegacy is not experiencing a shortage of non-human primates for research studies, and has animals available for immediate use. If your research plans or research partners have been impacted by the supply of NHPs, please contact PharmaLegacy and get your research timelines back on track. Let’s work together to find the next great treatment for human disease using research models of the highest quality and verified providence.

PharmaLegacy is deeply committed to the ethical and sustainable sourcing of animals for biomedical research. We understand it is a privilege to use animals including NHPs in research. As such, we follow the 3R (Replacement, Reduction and Refinement) to minimize animal use. We are an AAALAC accredited facility and completed triannual inspection and full re-accreditation last year.

More information on our animals, animal models, and their availability can be obtained by emailing info@pharmalegacy.com. More information on our NHP study capabilities can be found at https://pharmalegacy.com/services/non-human-primate-studies/